[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00011-1/abstract?utm_campaign=infocusalerts-oncology&utm_medium=email&dgcid=hubspot_email_infocusalerts-oncology_feature&_hsenc=p2ANqtz-8j55R0ctnw69-8l9ZYWQMzyP6mTsME9g7VhPorIuSv0jwn7ExGyRGzJ1tBEnPKW-5zJZwB9bEti1S2-X3jbX3jdkGKMw&_hsmi=356424055&utm_content=355487219&utm_source=hs_email